Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Autism Res ; 3(6): 303-10, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21182207

ABSTRACT

Asperger disorder (ASP) is one of the autism spectrum disorders (ASD) and is differentiated from autism largely on the absence of clinically significant cognitive and language delays. Analysis of a homogenous subset of families with ASP may help to address the corresponding effect of genetic heterogeneity on identifying ASD genetic risk factors. To examine the hypothesis that common variation is important in ASD, we performed a genome-wide association study (GWAS) in 124 ASP families in a discovery data set and 110 ASP families in a validation data set. We prioritized the top 100 association results from both cohorts by employing a ranking strategy. Novel regions on 5q21.1 (P = 9.7 × 10(-7) ) and 15q22.1-q22.2 (P = 7.3 × 10(-6) ) were our most significant findings in the combined data set. Three chromosomal regions showing association, 3p14.2 (P = 3.6 × 10(-6) ), 3q25-26 (P = 6.0 × 10(-5) ) and 3p23 (P = 3.3 × 10(-4) ) overlapped linkage regions reported in Finnish ASP families, and eight association regions overlapped ASD linkage areas. Our findings suggest that ASP shares both ASD-related genetic risk factors, as well as has genetic risk factors unique to the ASP phenotype.


Subject(s)
Asperger Syndrome/genetics , Polymorphism, Single Nucleotide/genetics , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Genetic Linkage/genetics , Genetic Predisposition to Disease/genetics , Genome-Wide Association Study/methods , Humans , Male , Risk Factors , Young Adult
2.
Mol Psychiatry ; 15(7): 736-47, 2010 Jul.
Article in English | MEDLINE | ID: mdl-19125159

ABSTRACT

Major depression and the metabolic syndrome (MetS) are interacting clinical conditions influenced by genetic susceptibility. For both disorders, impaired serotonergic neurotransmission in specific brain areas has been suggested. This led us to investigate whether variants in the gene coding for tryptophan hydroxylase 2 (TPH2), the brain-specific and rate-limiting enzyme for serotonin biosynthesis, might be predictive for an increased liability for the development of MetS in depressed patients. In a case-control study consisting of 988 patients with recurrent unipolar depression (RUD) and 1023 psychiatric healthy controls, MetS components were ascertained according to the International Diabetes Foundation criteria. A total of 41 single nucleotide polymorphisms fully covering the TPH2 gene region were genotyped in stage 1 (300 patients/300 controls), resulting in significant genetic associations of polymorphisms located in exon 7 and intron 8 of TPH2 and the occurrence of MetS in depressed patients after correction for age, gender and multiple testing (51 RUD-MetS/179 RUD-non-MetS). We were able to confirm the significant association of rs17110690 in stage 2 (688 patients/723 controls; 110 RUD-MetS/549 RUD-non-MetS) and to link risk-genotypes and risk-haplotypes for MetS to lower TPH2 mRNA expression and to lower 5-hydroxyindoleacetic acid levels in cerebrospinal fluid previously reported in functional studies. Our findings suggest that TPH2 polymorphisms characterize a subgroup of depressed patients who are especially prone to develop metabolic disorders induced by a genotype-dependent impairment of serotonergic neurotransmission. Identifying depressed patients at high risk for MetS using genetic variants could have direct clinical impact on individualized disease management and prevention strategies.


Subject(s)
Depressive Disorder/genetics , Genetic Predisposition to Disease/genetics , Metabolic Syndrome/genetics , Polymorphism, Single Nucleotide , Serotonin/genetics , Tryptophan Hydroxylase/genetics , Case-Control Studies , Depressive Disorder/complications , Depressive Disorder/enzymology , Female , Genetic Association Studies , Genotype , Humans , Male , Metabolic Syndrome/complications , Metabolic Syndrome/enzymology , Middle Aged , Serotonin/biosynthesis
3.
Mol Psychiatry ; 11(11): 1003-15, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16924268

ABSTRACT

Angiotensin-converting enzyme (ACE) is assumed to influence the activity of the hypothalamic-pituitary-adrenocortical (HPA) system, which shows hyperactivity in the majority of patients with major depression. The ACE gene, known to be associated with cardiovascular disorders, which in turn are accompanied with an increased susceptibility for depression, is therefore a promising candidate gene for affective disorders. We investigated the genetic association between 35 single-nucleotide polymorphisms (SNPs) and an insertion/deletion (I/D)-polymorphism in the ACE gene and the susceptibility for unipolar major depression together with the genetic association with ACE serum activity and functional parameters of the HPA system. Two independent case/control samples with a total of 843 unrelated unipolar depressed patients and 1479 healthy controls were investigated. A case/control sample was screened to detect genetic associations with unipolar major depression. In addition, a replication sample was used to confirm the detected associations and to further investigate functional consequences of the genetic variants associated with depression. In the screening sample, two SNPs within the ACE gene were significantly associated with unipolar major depression. The association with unipolar major depression of one SNP (rs4291) located in the promoter region of the ACE gene was confirmed in our replication sample. The T-allele of this SNP was associated with depression and depressed T-allele carriers showed higher ACE serum activity and HPA-axis hyperactivity. Variants of the ACE gene such as SNP rs4291 are suggested susceptibility factors for unipolar major depression. We could show that SNP rs4291 influences ACE activity and HPA-axis hyperactivity and might therefore represent a common pathophysiologic link for unipolar depression and cardiovascular disease.


Subject(s)
Chromosomes, Human, Pair 17/genetics , Cushing Syndrome/genetics , Depressive Disorder/genetics , Genetic Predisposition to Disease/genetics , Peptidyl-Dipeptidase A/genetics , Adult , Aged , Cardiovascular Diseases/complications , Cardiovascular Diseases/genetics , Case-Control Studies , Depressive Disorder/complications , Enzyme Activation/genetics , Female , Gene Deletion , Humans , Hypothalamo-Hypophyseal System/metabolism , Linkage Disequilibrium , Male , Matched-Pair Analysis , Middle Aged , Peptidyl-Dipeptidase A/metabolism , Pituitary-Adrenal System/metabolism , Polymorphism, Single Nucleotide , Promoter Regions, Genetic/genetics , Reference Values , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL